Market Research > Welcome to MarketResearch.com

FirstWord

FirstWord belongs to a business group that forms one of the world's largest healthcare knowledge networks. Drawing from these knowledge assets, FirstWord reports deliver insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date, actionable intelligence - reports that deliver vital intelligence to give a competitive edge.

List of reports from FirstWord

Leveraging the Influence of Patient Opinion Leaders and Patient Groups 10/19/2023 \| published by: FirstWord ... Advocacy Groups (PAGs) can play a critical role in pharma, from clinical trial design/recruitment to HCP decision-making and regulator/payer support. However, pharma must demonstrate that patient relationships are ethical and compliant with regulations/guidelines. So, what ... \| read more...
Driving Excellence in MSL-KOL Engagement 10/19/2023 \| published by: FirstWord ... face-to-face interactions remain valuable, MSLs and KOLs are finding novel ways to maintain their collaborations and exchange scientific information. So, as the sector continues to evolve, what are the pros and cons of virtual interactions? ... \| read more...
The Role of Wearable Technology in Drug Development 10/11/2023 \| published by: FirstWord ... studies to post-marketing, surveillance has applications across the drug development landscape. So, how and where can wearables best support your clinical research program? How can it deliver a 360-degree view of the patient? What role ... \| read more...
Closing the Maturity Gap in Connected Health 9/14/2023 \| published by: FirstWord ... technologies can deliver real-world data to inform the development/commercialisation of new therapies, improve patient outcomes and help differentiate products in crowded markets. However, challenges around data security, complex reimbursement frameworks, regulatory barriers and service personalisation ... \| read more...
Leveraging RWD and RWE to drive marketing effectiveness 9/1/2023 \| published by: FirstWord ... a drug is becoming increasingly influential in stakeholder decision-making. But how effectively are you using RWD/E to drive the effectiveness of your marketing? How can RWD/E demonstrate a drug’s long-term effectiveness and encourage physicians to ... \| read more...
Medical Communications: Moving From Push To Pull 8/25/2023 \| published by: FirstWord ... a platform of their choice. Traditional communications such as conferences and email are no longer the engagement panacea they once were. So, how can pharma strike the right balance between push and pull communications? What ... \| read more...
Market Access Strategies for Prescription Digital Therapeutics 8/25/2023 \| published by: FirstWord ... up their market access game to win stakeholder support. The approach they take will shape their market access strategy. So, how can you get payers onside? What are the reimbursement challenges? Where will patients need ... \| read more...
Digital Opinion Leaders: Unlocking New Engagement Opportunities 8/4/2023 \| published by: FirstWord ... can be wide, such as effectively engaging with underserved or rare disease communities. DOLs represent an untapped opportunity for pharma to better understand patients, target marketing and influence payers—but only if operational challenges such as ... \| read more...
Overcoming physician barriers to increase DTx adoption 7/31/2023 \| published by: FirstWord ... positive about the value of DTx, they remain cautious about the broader impacts. Concerns about increased administration, integration into clinical workflows, the risks associated with DTx use, and the need for better patient support and ... \| read more...
Innovations in medication adherence 7/4/2023 \| published by: FirstWord ... a loss of revenue, negative perceptions about the real-world efficacy of a drug and even undermine the prospects of products conditionally approved based on real-world outcomes. So, what role can pharma play in really changing ... \| read more...
The ICER Effect: Payer Perspectives 6/30/2023 \| published by: FirstWord ... US drug market. But what does pharma need to know about how they resonate with payers? How do payers view ICER and its methodology? In what ways are payers using ICER assessments, and to what ... \| read more...
Next-Generation Wearables: Applications and Opportunities for Pharma 6/28/2023 \| published by: FirstWord ... and disease management insights. So how does pharma benefit? How can wearables and digital biomarkers demonstrate the clinical value of a new medicine? How might they improve clinical trials and drug delivery? What are the ... \| read more...
Pricing and Reimbursement of Hospital Drugs in the US 6/15/2023 \| published by: FirstWord ... Part B hospital drug expenditure has grown from $28.4 billion in 2017 to $40.1 billion in 2021. The average expenditure per beneficiary has risen from $818 in 2017 to $1275 in 2021. But which companies ... \| read more...
Leveraging RWE to Widen Access to Therapies and Disrupt Treatment Pathways 6/6/2023 \| published by: FirstWord ... the pre- and post-approval drug process, it can deliver even greater value. RWE has the potential to influence HTA and payers, enabling long-term access and the reassessment of drugs to ensure treatment availability to expanded ... \| read more...
Digital Health Collaborations to Accelerate Earlier Diagnosis and Treatment 6/1/2023 \| published by: FirstWord ... treatment and management of disease and when does specialist technology partnering make sense? With improved internal digital capabilities pharma now better understands where and when digital expertise can add value. So, when are tech collaborations ... \| read more...
Leveraging AI to Support Strategic Go-To-Market Decisions 5/16/2023 \| published by: FirstWord ... payer scrutiny, and the move towards value-based healthcare have made launching products challenging. Making effective commercial decisions depends on the interpretation of multiple data sources and AI can help shape go-to-market strategies in key areas ... \| read more...
Data Driven CRM in Pharma: challenges and opportunities 5/15/2023 \| published by: FirstWord ... is cited by customers as a determining factor for their purchasing decisions. Old, siloed marketing models will not work. Adopting a fully integrated data strategy that combines customer data with an intelligent picture of local ... \| read more...
Digital Biomarkers: Impact on future clinical development and outcomes 5/10/2023 \| published by: FirstWord ... progress, the acceptance and adoption of digital biomarkers remains limited. What are the verification, analytical and clinical validation processes and technologies needed to develop the digital tools that can drive superior clinical research and patient ... \| read more...
AI revolution: transforming rare disease research and development 4/14/2023 \| published by: FirstWord ... rates of diagnosis and geographical dispersion. But AI-enabled technologies are changing the rare disease research landscape. By integrating and analysing data from different multi-omics and multi-modal sources, AI is already accelerating the development of new ... \| read more...	USD 5,950
Medical Affairs Digital Transformation 4/14/2023 \| published by: FirstWord ... dash for digital in Medical Affairs is seen as critical to the function’s strategic development. But as the number of digital solutions grows, which will deliver real-world engagement and workflow benefits? Why should you be ... \| read more...
Trends in HCP Engagement (2023) 4/11/2023 \| published by: FirstWord ... shift from HCPs to other stakeholder groups such as payers and patients? What emphasis will be placed on personalised content marketing? What role will AI/ML play in better understanding HCPs preferences? In this comprehensive survey ... \| read more...	USD 5,950
Medical Affairs’ Role in Breaking Down Silos in Pharma 3/31/2023 \| published by: FirstWord ... locally but might not be aligned to an organisation’s overall strategy and vision. Medical Affairs (MA) are uniquely placed to lead on breaking down silos but what organisational structural changes are required and what skills ... \| read more...	USD 5,950
Choosing the Right Channel Mix to Maximise KOL Engagement 3/23/2023 \| published by: FirstWord ... building these relationships. But the rapid growth in the number of digital channels has saturated the market leading to KOL digital fatigue. How can you punch through the noise to really get your messages to ... \| read more...	USD 5,950
Leveraging Personalised Content to Effectively Engage with HCPs 3/20/2023 \| published by: FirstWord ... from pharma. They want specific, easily consumed, accessible and shareable data that shows a greater understanding of their needs. So, how can pharma tailor its content to reflect HCPs’ preferences? What are the benefits of ... \| read more...	USD 5,950
AI Opportunities in Personalised Medicine 3/15/2023 \| published by: FirstWord ... data, laboratory tests, electronic health records and real-world data, AI is unlocking a deep understanding of the pathology of diseases and their treatment. So how and where can pharma best leverage value from its AI ... \| read more...	USD 5,950

< prev 1 2 next >